Medicinova (MNOV)
NASDAQ:MNOV
Holding MNOV?
Track your performance easily

Medicinova (MNOV) Stock Price & Analysis

290 Followers

MNOV Stock Chart & Stats


Financials

Annual

Ownership Overview

2.98%2.64%2.61%90.28%
2.98%
Insiders
2.61% Other Institutional Investors
90.28% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

MNOV FAQ

What was Medicinova’s price range in the past 12 months?
Medicinova lowest stock price was $1.12 and its highest was $2.16 in the past 12 months.
    What is Medicinova’s market cap?
    Currently, no data Available
    When is Medicinova’s upcoming earnings report date?
    Medicinova’s upcoming earnings report date is Apr 26, 2023 which is 566 days ago.
      How were Medicinova’s earnings last quarter?
      Medicinova released its earnings results on Jul 27, 2022. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.087 by -$0.063.
        Is Medicinova overvalued?
        According to Wall Street analysts Medicinova’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Medicinova pay dividends?
          Medicinova does not currently pay dividends.
          What is Medicinova’s EPS estimate?
          Medicinova’s EPS estimate is -$0.07.
            How many shares outstanding does Medicinova have?
            Medicinova has 49,046,246 shares outstanding.
              What happened to Medicinova’s price movement after its last earnings report?
              Medicinova reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.087. Following the earnings report the stock price went down -1.835%.
                Which hedge fund is a major shareholder of Medicinova?
                Currently, no hedge funds are holding shares in MNOV
                ---

                Medicinova Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                -14.04%
                12-Months-Change

                Fundamentals

                Return on Equity
                -13.32%
                Trailing 12-Months
                Asset Growth
                -12.10%
                Trailing 12-Months

                Company Description

                Medicinova

                MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                ANI Pharmaceuticals
                EyePoint Pharmaceuticals
                Kiniksa Pharmaceuticals
                Immutep
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis